Prot #CAB-201-001: A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T cells (CABA-201) in Subjects with Active Systemic Lupus Erythematosus

  • Blanco, Irene (PD/PI)
  • Wadhwani, Shikha (PD/PI)
  • Wadhwani, Shikha (PD/PI)

Project: Research project

Project Details

StatusActive
Effective start/end date2/26/248/30/27

Funding

  • Cabaletta Bio, Inc. (Prot #CAB-201-001 AMD 2)